Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Development of directly compressible excipients from Phoenix dactylifera (Date) mucilage and microcrystalline cellulose using co-processing techniques

The objective of this study was to harness the excipient potential of date mucilage by co-grinding and co-fusing with avicel for enhanced performance in the directcompression of metronidazole. Co-grinding and co-fusing of parent polymers were done using established methods and excipients were used i...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2018
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/13260
042 |a dc 
720 |a Akin-Ajani, O. D  |e author 
720 |a Ajala, T. O  |e author 
720 |a Okoli, U. M.  |e author 
720 |a Okonta, O  |e author 
260 |c 2018 
520 |a The objective of this study was to harness the excipient potential of date mucilage by co-grinding and co-fusing with avicel for enhanced performance in the directcompression of metronidazole. Co-grinding and co-fusing of parent polymers were done using established methods and excipients were used in the direct-compression of metronidazole tablets. The shape and surface morphology of the particles of date mucilage (DAM) and co-processed excipients were generally granular, rough and irregular. There was a significant improvement in the disintegration of tablets prepared using the coprocessed excipients in comparison to that prepared using DAM alone. The disintegration time for tablets prepared using co-fused excipients was lower than that of co-grinded additives although the differences were not significant (p > 0.05). Generally, the co-processed excipients improved the mechanical and disintegration properties of the tablets produced compared to tablets prepared using DAM alone and could be further developed as direct compression excipients 
024 8 |a 2636‑8552 
024 8 |a ui_art_akin-ajani_development_2018 
024 8 |a Acta Pharmaceutica Sciencia 56(3) P.7 – 25 
024 8 |a https://repository.ui.edu.ng/handle/123456789/13260 
653 |a Date mucilage 
653 |a avicel 
653 |a co-processing 
653 |a metronidazole tablets. 
245 0 0 |a Development of directly compressible excipients from Phoenix dactylifera (Date) mucilage and microcrystalline cellulose using co-processing techniques